Unverified50% confidenceFactExact time
The glymphatic clearance hypothesis faces controversy: imaging methods vary in reproducibility across laboratories; the causal relationship between AQP4 polarity loss and disease progression has not been fully established; and there is a lack of large-scale human trial evidence on whether enhancing glymphatic clearance can truly improve clinical outcomes.
1
Sources
50%
Confidence
Long-term
Relevance
10/24/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedAnti-Aβ antibody drugs developed based on the amyloid hypothesis have repeatedly stumbled in clinical trials, either failing to significantly improve cognition or being forced to terminate due to side effects such as brain edema.66% similarUnverifiedWhen AQP4 polarity is lost (such as in aging, ischemia or neurodegenerative disease), glymphatic flow rate drops significantly.65% similarUnverifiedAlthough anti-amyloid drugs can significantly reduce plaque burden in clinical trials, cognitive improvement is often limited.61% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1094274API
curl https://kongchang.com/api/v1/knowledge/claims/1094274MCP
get_claim(id=1094274)